EODData

MEMBERSHIP REGISTER LOG IN

ASX, CU6: Clarity Pharmaceuticals Ltd.

17 Mar 2026
LAST:

3.400

CHANGE:
 0.22		OPEN:
4.070		HIGH:
4.260		ASK:
3.420		VOLUME:
5.06M
CHG(%):
6.08		PREV:
3.620		LOW:
3.375		BID:
3.370		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
17 Mar 264.0704.2603.3753.4005.06M
16 Mar 263.7503.8503.5903.6201.29M
13 Mar 263.7303.9303.6603.8301.4M
12 Mar 263.9504.0053.6303.7901.86M
11 Mar 263.5103.9803.4803.9602.54M
10 Mar 263.5103.5803.3403.5102.16M
09 Mar 263.4003.4703.2103.2901.67M
06 Mar 263.3803.6103.3403.5801.16M
05 Mar 263.2203.4903.2003.4701.64M
04 Mar 263.3003.4403.0703.1101.66M

PROFILE

Name:Clarity Pharmaceuticals Ltd.
About:Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, engages in research and development of radiopharmaceuticals products for oncology in Australia and the United States. The company's lead product is SAR-bisPSMA, a theranostic radiopharmaceutical for the treatment of Prostate Specific Membrane Antigen (PSMA) cancer. It also develops SAR-Bombesin, a pan cancer theranostic radiopharmaceutical to treat prostate, breast, ovarian, urinary, small cell lung cancer, as well as glioblastoma and gastrointestinal stromal tumours; and SARTATE, a theranostic radiopharmaceutical for the treatment of somatostatin receptor 2 (SSTR2) cancer. The company was incorporated in 2010 and is based in Sydney, Australia.
Sector:Healthcare
Industry:Biotechnology
Address:National Innovation Centre, Sydney, NSW, Australia, 2015
Website:https://www.claritypharmaceuticals.com
ISIN:AU0000165375
FIGI:BBG011WVJ0K9

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-16.72 
Forward P/E:-16.76 
PEG Ratio:-14.51 
Price to Sales:132.10 
Price to Book:13.81 
Operating Margin:-8.23 
Return on Assets:-0.34 
Return on Equity:-0.54 
EPS Ratio:-0.20 
Revenue:9.46M 
Shares:372.03M 
Market Cap:1.265B 

TECHNICAL INDICATORS

MA5:3.729.4%
MA10:3.564.6%
MA20:3.564.6%
MA50:3.410.4%
MA100:3.605.9%
MA200:3.574.9%
STO9:11.34 
STO14:25.22
RSI14:43.53
WPR14:-65.88
MTM14:-0.20
ROC14:-0.06 
ATR:0.36 
Week High:4.2625.3%
Week Low:3.341.8%
Month High:4.2625.3%
Month Low:3.074.9%
Year High:5.8772.6%
Year Low:1.43137.8%
Volatility:86.17